News|Articles|December 2, 2002
- Pharmaceutical Technology-12-02-2002
- Volume 26
- Issue 12
Generic Drugs Take Center Stage
Author(s)Jill Wechsler
Reform legislation about generic drugs remains at the forefront of debate as innovator companies poise to challenge FDA proposals regarding patent laws.
Advertisement
Articles in this issue
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Six New and Nine Indication Extension Recommendations from EMA’s CHMP
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
4
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
5